Trabectedin, also known by its historical designation ET-743 or Ecteinascidin 743, and identified by CAS 114899-77-3, is a marine-derived natural product that has found a significant place in modern oncology. Its complex structure and potent cytotoxic activity make it a valuable compound for research and pharmaceutical development aimed at treating challenging forms of cancer.

The efficacy of Trabectedin is attributed to its unique mechanism of action. It functions by binding to the minor groove of DNA, which subsequently impedes crucial cellular processes, including transcription and DNA repair. This interference leads to the induction of DNA double-strand breaks and ultimately promotes apoptosis in cancer cells. Its clinical utility is well-established in the treatment of advanced soft tissue sarcomas and ovarian cancers, often serving as a critical option for patients who have not responded to other therapies.

For scientists and procurement professionals engaged in pharmaceutical R&D, securing a reliable and high-quality source for Trabectedin is paramount. As a leading manufacturer and supplier, we are committed to providing researchers with access to this complex molecule. When you decide to buy Trabectedin (ET-743), it is essential to partner with a company that emphasizes purity and batch consistency. Our role as a global supplier ensures that we meet the diverse needs of the pharmaceutical industry.

We offer Trabectedin (CAS 114899-77-3) at a competitive price, especially for bulk requirements, supporting extensive research initiatives. If your organization is looking to purchase Trabectedin for advanced cancer research or drug development, we encourage you to reach out. We pride ourselves on our ability to provide high-quality pharmaceutical intermediates, backed by a robust supply chain and excellent customer support. Partner with us to ensure your research projects have access to this vital antineoplastic agent.